EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Dementia in health claims data: The influence of different case definitions on incidence and prevalence estimates

Oliver Riedel iD, Malte Braitmaier, Ingo Langner

International Journal of Methods in Psychiatric Research · 2023-06 · 32 (2)

DOI: 10.1002/mpr.1947 ↗

At a glance

Journal article in International Journal of Methods in Psychiatric Research, published online on 2022-09-27. Written by Oliver Riedel and 2 co-authors. Institution: Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany. Major MEDLINE topics: Alzheimer Disease, Dementia, Vascular. Cited 10 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objectives

The epidemiology of dementia subtypes including Alzheimer's disease (AD) and vascular dementia (VD) and their reliance on different case definitions (“algorithms”) in health claims data are still understudied.

Methods

Based on health claims data, prevalence estimates (per 100 persons), incidence rates (IRs, per 100 person‐years), and proportions of AD, VD, and other dementias (oD) were calculated. Five algorithms of increasing strictness considered inpatient/outpatient diagnoses (#1, #2), antidementia drugs (#3) or supportive diagnostics (#4, #5).

Results

Algorithm 1 detected 213,409 cases (#2: 197,400; #3: 48,688; #4: 3033; #5: 3105), a prevalence for any dementia of 3.44 and an IR of 1.39 (AD: 0.80/0.21, VD: 0.79/0.31). The prevalence decreased by algorithms for any dementia (#2: 3.19; #3: 0.75; #4: 0.04; #5: 0.05) as did IRs (#2: 1.13; #3: 0.18; #4: 0.05, #5: 0.05). Algorithms 1–2, and 4–5 revealed similar proportions of AD (23.3%–26.6%), VD (19.9%–23.2%), and oD (53.1%–53.8%), algorithm 3 estimated 45% (AD), 12.1% (VD), and 43.0% (oD).

Conclusions

Health claims data show lower estimates of AD than previously reported, due to markedly lower prevalent/incident proportions of patients with corresponding codes. Using medication in defining dementia potentially improves estimating the proportion of AD while supportive diagnostics were of limited use.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseDementia, VascularHumansIncidencePrevalenceAlgorithms

Author keywords

Alzheimer's diseasedementiaepidemiologyhealth claims datavascular dementia

Authors and institutions

  • Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.

ORCID profiles: Oliver Riedel

Cite

APA

Riedel, O., Braitmaier, M., & Langner, I. (2023). Dementia in health claims data: The influence of different case definitions on incidence and prevalence estimates. International Journal of Methods in Psychiatric Research, 32(2). https://doi.org/10.1002/mpr.1947

Vancouver

Riedel O, Braitmaier M, Langner I. Dementia in health claims data: The influence of different case definitions on incidence and prevalence estimates. International Journal of Methods in Psychiatric Research. 2023;32(2). doi:10.1002/mpr.1947

BibTeX
@article{Riedel2023,
  author = {Riedel, Oliver and Braitmaier, Malte and Langner, Ingo},
  title = {Dementia in health claims data: The influence of different case definitions on incidence and prevalence estimates},
  journal = {International Journal of Methods in Psychiatric Research},
  year = {2023},
  volume = {32},
  number = {2},
  doi = {10.1002/mpr.1947}
}
Start for free →